Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 6;22:791–802. doi: 10.1016/j.omtn.2020.10.001

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Author(s)

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Therapeutic Effects of Intraperitoneal Administration of AmNA-Modified anti-SYT13 ASOs

(A) IVIS analysis of representative mice in each treatment group, 3 weeks after engraftment with MKN1 cells. (B) Macroscopic appearance of peritoneal nodules, 6 weeks after implantation of MKN1 cells, and comparison of the total volume of peritoneal nodules in each treatment group. (C) The macroscopic appearance of satellite mice 8 weeks after implantation of NUGC4 cells. (D) Survival of mice treated with intraperitoneal administration of vehicle, ASO-NEG, hSYT13-4378, or hSYT13-4733. Error bars indicate the standard deviation.